Esra Arslan Aksu


COVID-19 is an infectious disease caused by the SARS-Cov-2, and it was first reported in Wuhan province of China. RT-PCR test for viral nucleic acids in the diagnosis of COVID-19 is the gold standard method. However, when the number of patients admitted to the emergency department is too high, it may take a long time to result in the PCR test. In areas where suspicious cases are followed in isolation, possible PCR negative cases are also at risk. In the study, the data of patients who were admitted to the emergency department of Samsun Training and Research Hospital with the suspicion of COVID-19 in the years 2020-2021 were analyzed retrospectively. Laboratory and chest CT images were examined through the hospital's information processing system. The C-Reactive Protein (CRP), D-dimer, White Blood Cell (WBC) count, and Eosinophil count of the patients admitted as suspicious cases were evaluated. Chest CT images were evaluated according to the CO-RADS classification. A statistically significant difference was found between PCR positive and negative patients in terms of eosinophil count, CRP, d-dimer and CO-RADS classification. In our study, tests were evaluated at the stage of making a faster and more accurate diagnosis. In addition, the patient group included in our study is a specific group of patients who did not receive any medical treatment that could affect the results of the examination. As a result, when our study and previous studies are evaluated, CRP, d-dimer, eosinophil count and computerized tomography are the tests that can be used in the diagnosis of COVID-19. And examinations can be used in units where rapid diagnosis is required, such as emergency services.


Article visualizations:

Hit counter


COVID-19, diagnostic tests, emergency department

Full Text:



An, J. Y., Unsdorfer, K. M., & Weinreb, J. C. (2019). BI-RADS, C-RADS, CAD-RADS, LI-RADS, Lung-RADS, NI-RADS, O-RADS, PI-RADS, TI-RADS: Reporting and Data Systems. Radiographics, 39(5), 1435-1436.

Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D. Y., Chen, L., & Wang, M. (2020). Presumed asymptomatic carrier transmission of COVID-19. Jama, 323(14), 1406-1407.

Chen, G., Wu, D. I., Guo, W., Cao, Y., Huang, D., Wang, H., & Ning, Q. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. The Journal of clinical investigation, 130(5), 2620-2629.

Fahmi, I. (2019). World Health Organization coronavirus disease 2019 (Covid-19) situation report. DroneEmprit.

Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., & Wang, L. (2020). Diagnostic utility of clinical laboratory data determinations for patients with severe COVID‐19. Journal of medical virology, 92(7), 791-796.

Li, Y. Y., Wang, W. N., Lei, Y., Zhang, B., Yang, J., Hu, J. W., & Lu, Q. F. (2020). Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with coronavirus disease 2019. Zhonghua Jie He He Hu Xi Za Zhi, 427-430.

McInnes, M. D., Moher, D., Thombs, B. D., McGrath, T. A., Bossuyt, P. M., Clifford, T., ... & Willis, B. H. (2018). Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. Jama, 319(4), 388-396

Qian, G. Q., Yang, N. B., Ding, F., Ma, A. H. Y., Wang, Z. Y., Shen, Y. F., & Chen, X. M. (2020). Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM: An International Journal of Medicine, 113(7), 474-481.

World Health Organization. (2020). Laboratory testing for coronavirus disease 2019 (‎ COVID-19)‎ in suspected human cases: interim guidance, 2 March 2020 (No. WHO/COVID-19/laboratory/2020.4). World Health Organization.

Zhang, B., Zhou, X., Zhu, C., Song, Y., Feng, F., Qiu, Y., & Wang, J. (2020). Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Frontiers in molecular biosciences, 7, 157.

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine.



  • There are currently no refbacks.

Copyright (c) 2022 Esra Arslan Aksu

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2019 - 2023. European Journal of Public Health Studies (ISSN 2668-1056/ISSN-L 2668-1056) is a registered trademark of Open Access Publishing Group. All rights reserved.

This journal is a serial publication uniquely identified by an International Standard Serial Number (ISSN) serial number certificate issued by Romanian National Library. All the research works are uniquely identified by a CrossRef DOI digital object identifier supplied by indexing and repository platforms. All the research works published on this journal are meeting the Open Access Publishing requirements and standards formulated by Budapest Open Access Initiative (2002), the Bethesda Statement on Open Access Publishing (2003) and Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities (2003) and can be freely accessed, shared, modified, distributed and used in educational, commercial and non-commercial purposes under a Creative Commons Attribution 4.0 International License. Copyrights of the published research works are retained by authors.